儿童急性缺血性卒中的血管内治疗:MR CLEAN登记研究经验
该研究回顾性分析了MR CLEAN登记中2014年3月至2017年7月接受血管内治疗的9例前循环急性缺血性卒中患儿,年龄13个月至16岁。结果显示血管内治疗在儿童中似乎安全可行,5例存活者6个月随访均获得良好预后(mRS 0-2),但4例左心室辅助装置患儿中2例死亡,需更大样本研究权衡风险与获益。
要点
- 儿童前循环急性缺血性卒中血管内治疗技术成功率高,围手术期无重大并发症。
- 9例患儿中5例存活,6个月随访mRS均0-2分,预后良好。
- 左心室辅助装置患儿预后差,4例中2例死亡,需谨慎评估。
核心结论
- 儿童急性缺血性卒中的血管内治疗似乎安全可行。
- 需更大规模研究明确该治疗在儿童中的风险与获益权衡。
研究设计与样本
- 回顾性分析MR CLEAN登记中2014年3月至2017年7月接受血管内治疗的9例18岁以下前循环急性缺血性卒中患儿,随访至术后6个月。
主要发现
- 9例患儿年龄13个月至16岁(中位14岁,四分位距3-15岁),卒中病因在4例左心室辅助装置终末期心力衰竭患儿中为血栓栓塞。
- 发病至影像中位时间133分钟,4例患儿术前接受静脉阿替普酶治疗,中位发病至穿刺时间165分钟。
- 除1例外血管内治疗技术成功,无重大围手术期并发症。
- 术后24小时,3例完全恢复,4例部分恢复(中位NIHSS 3.5),2例左心室辅助装置患儿第一周内死于多发卒中。
- 1例左心室辅助装置患儿发生致命性大面积颅内出血,另1例患儿死于左心室辅助装置相关并发症。
临床怎么用
- 儿童前循环急性缺血性卒中可考虑血管内治疗,但需个体化评估,尤其左心室辅助装置患儿风险较高。
- 治疗决策应结合多学科团队意见,并充分告知家属预后不确定性。
局限性
- 样本量小(仅9例),为回顾性研究,结论需谨慎解读。
- 缺乏儿童随机对照试验数据,长期疗效和安全性尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Multiple trials have shown the efficacy and safety of endovascular therapy (EVT) of acute ischemic stroke in adults. Trials in children are lacking and only case reports and case series exist. However, the long-term outcome of children with acute ischemic stroke can be devastating with significant mortality and morbidity. In this study, we describe the safety and efficacy of EVT in children with anterior circulation acute ischemic stroke who were included in the MR CLEAN Registry (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). METHODS: Patients under the age of 18 years who were treated with EVT for acute ischemic stroke between March 2014 and July 2017 were retrospectively reviewed up to 6 months after EVT. Nine children, aged 13 months to 16 years (median 14 years, interquartile range, 3-15 years), underwent EVT. Stroke cause was thromboembolism in children with end-stage heart failure on left ventricular assist device (4 of these 9 cases). Median time from onset to imaging was 133 minutes. Four children received intravenous alteplase before EVT, with median onset to needle time of 165 minutes. In all but one patient, EVT was technically successful. No major periprocedural complications occurred. RESULTS: At 24 hours after EVT, 3 children completely recovered and 4 children showed partial recovery (median National Institutes of Health Stroke Scale, 3.5), whereas 2 patients on left ventricular assist device died within the first week due to the occurrence of multiple strokes. One patient on left ventricular assist device developed a fatal massive intracranial hemorrhage and another child died due to left ventricular assist device-related complications. Among the 5 stroke survivors, all had a favorable outcome (modified Rankin Scale score, 0-2) at 6 months follow-up. CONCLUSIONS: EVT of children with acute ischemic stroke seems safe and feasible. However, these findings should be interpreted with caution as more and larger studies are needed to clarify the trade-off between risks and benefits of this treatment.
引用
- van Es ACGM, Hunfeld MAW, van den Wijngaard I, et al. Endovascular Treatment for Acute Ischemic Stroke in Children: Experience From the MR CLEAN Registry. Stroke. 2021. PMID: 33617341. doi:10.1161/STROKEAHA.120.030210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。